New NCCN Guidelines Navigator for breast cancer genetic testing and treatment
The National Comprehensive Cancer Network (NCCN) is sharing new NCCN Guidelines Navigator resources for breast cancer treatment as well as genetic/familial high-risk assessment. Lurie Cancer Center is a founding member of NCCN, a not-for-profit alliance of leading cancer centers responsible for globally utilized guidelines for cancer care. The new tool’s interactive format makes recommendations easier to navigate and search and links directly to other NCCN digital resources.
The NCCN Guidelines Navigator features content from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)—the most frequently-updated clinical practice guidelines available in any area of medicine. NCCN Guidelines® cover everything from cancer prevention, to screening, diagnosis, treatment, survivorship, and supportive care. The new format incorporates seamless movement, advanced search and filter capabilities, color-coded navigation links, and other digital enhancements.
“The NCCN Guidelines were accessed more than 16 million times in the last calendar year overall—with the breast cancer treatment guidelines accounting for about 10 percent of that total,” said Lurie Cancer Center’s William J. Gradishar, MD, Chair of the NCCN Guidelines Panel for Breast Cancer. “Breast cancer prevention, screening, and management is based on complex and rapidly evolving information, impacting millions of people worldwide. We’ve seen survival rates improve dramatically thanks to scientific advances that help health care providers match the right approach to the right person. The new NCCN Guidelines Navigator format allows us to integrate different resources for improving care into one hub for clinical guidance, patient/caregiver empowerment, and professional development.”